Yingyuan Lu

484 total citations
48 papers, 362 citations indexed

About

Yingyuan Lu is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Yingyuan Lu has authored 48 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 12 papers in Complementary and alternative medicine and 9 papers in Pharmacology. Recurrent topics in Yingyuan Lu's work include Traditional Chinese Medicine Analysis (12 papers), Metabolomics and Mass Spectrometry Studies (11 papers) and Ginseng Biological Effects and Applications (8 papers). Yingyuan Lu is often cited by papers focused on Traditional Chinese Medicine Analysis (12 papers), Metabolomics and Mass Spectrometry Studies (11 papers) and Ginseng Biological Effects and Applications (8 papers). Yingyuan Lu collaborates with scholars based in China, United States and Taiwan. Yingyuan Lu's co-authors include Pengfei Tu, Yong Jiang, Xiaoyu Guo, Zhiyong Du, Jinlong Wang, Peng Gao, Mingbo Zhao, Meng Fang, Jinfeng Chen and Jun Li and has published in prestigious journals such as Analytical Chemistry, Journal of Hazardous Materials and Scientific Reports.

In The Last Decade

Yingyuan Lu

45 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingyuan Lu China 12 187 68 68 35 34 48 362
Amitava Dasgupta United States 12 184 1.0× 80 1.2× 76 1.1× 25 0.7× 24 0.7× 43 492
Lihui Men China 11 269 1.4× 71 1.0× 55 0.8× 24 0.7× 35 1.0× 25 403
Byung Hyuk Han South Korea 11 190 1.0× 71 1.0× 59 0.9× 33 0.9× 38 1.1× 30 361
Andreea Liana Răchişan Romania 8 141 0.8× 51 0.8× 41 0.6× 26 0.7× 59 1.7× 25 523
Shitang Ma China 14 206 1.1× 73 1.1× 61 0.9× 34 1.0× 36 1.1× 53 537
Huanhuan Ren China 12 275 1.5× 91 1.3× 92 1.4× 43 1.2× 52 1.5× 26 544
Tianwei Dong China 6 251 1.3× 56 0.8× 89 1.3× 33 0.9× 20 0.6× 10 376
Youli Lu China 11 136 0.7× 39 0.6× 84 1.2× 22 0.6× 16 0.5× 23 335
Dian Kang China 13 251 1.3× 93 1.4× 60 0.9× 11 0.3× 26 0.8× 26 370
Tianyi Xia China 14 179 1.0× 41 0.6× 32 0.5× 17 0.5× 35 1.0× 26 393

Countries citing papers authored by Yingyuan Lu

Since Specialization
Citations

This map shows the geographic impact of Yingyuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingyuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingyuan Lu more than expected).

Fields of papers citing papers by Yingyuan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingyuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingyuan Lu. The network helps show where Yingyuan Lu may publish in the future.

Co-authorship network of co-authors of Yingyuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingyuan Lu. A scholar is included among the top collaborators of Yingyuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingyuan Lu. Yingyuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Du, Zhiyong, Yingyuan Lu, Yunxiao Yang, et al.. (2025). The prognostic and therapeutic significance of polyunsaturated fatty acid‐derived oxylipins in ST‐segment elevation myocardial infarction. iMeta. 4(1). e266–e266. 5 indexed citations
3.
Yuan, Shuo, Peng Gao, Jun Lei, et al.. (2025). Multi-omics analysis reveals the mechanism of Cistanche deserticola against alcoholic liver disease via bile salt hydrolase and SCD1. Journal of Ethnopharmacology. 355(Pt A). 120626–120626.
4.
Li, Xiaoshuang, et al.. (2025). Pharmacokinetic study of eighteen components from aqueous extract of Corydalis Decumbentis Rhizoma in normal and MCAO rats. Journal of Ethnopharmacology. 349. 119963–119963. 1 indexed citations
5.
Du, Zhiyong, Yu Wang, Xiang Fang, et al.. (2025). Bacteroides vulgatus alleviates heart failure via butyric acid-TGF-β1/MAPK pathway. Journal of Advanced Research.
6.
Xu, Yisheng, et al.. (2024). Identification strategy of wild and cultivated Astragali Radix based on REIMS combined with two-dimensional LC-MS. npj Science of Food. 8(1). 91–91. 1 indexed citations
7.
Liu, Yuhua, Zhiyong Du, Yingyuan Lu, et al.. (2024). Gut microbiota metabolism disturbance is associated with postoperative atrial fibrillation after coronary artery bypass grafting. PubMed. 1(1). 4 indexed citations
8.
Chen, Xin, Yizhen Bai, Peng Gao, et al.. (2024). Palmitoylation of PKCδ by ZDHHC5 in hypothalamic microglia presents as a therapeutic target for fatty liver disease. Theranostics. 14(3). 988–1009. 19 indexed citations
9.
Lu, Yingyuan, et al.. (2024). Development of an integrated strategy for comprehensive characterization of Sinomenii Caulis extract and metabolites in rats based on UPLC/Q-TOF-MS. Journal of Pharmaceutical and Biomedical Analysis. 249. 116391–116391. 2 indexed citations
10.
Gao, Peng, Shuo Yuan, Ke‐Wu Zeng, et al.. (2023). Exploring the Mechanism of Hepatotoxicity Induced by Dictamnus dasycarpus Based on Network Pharmacology, Molecular Docking and Experimental Pharmacology. Molecules. 28(13). 5045–5045. 10 indexed citations
11.
Yan, Jiaqing, Zhe Chen, Mingyu Zhang, et al.. (2023). The roles of ubiquitin–proteasome system and regulator of G protein signaling 4 in behavioral sensitization induced by a single morphine exposure. Brain and Behavior. 13(3). e2922–e2922. 2 indexed citations
12.
Li, Tianyu, et al.. (2023). Efficient degradation of hexabromocyclododecane using montmorillonite supported nano-zero-valent iron and Citrobacter sp. Y3. Journal of Hazardous Materials. 457. 131739–131739. 6 indexed citations
13.
Fang, Meng, Zhiyong Du, Yong Jiang, et al.. (2022). The Synergistic Mechanism of Total Saponins and Flavonoids in Notoginseng–Safflower against Myocardial Infarction Using a Comprehensive Metabolomics Strategy. Molecules. 27(24). 8860–8860. 6 indexed citations
14.
Peng, Xingxing, et al.. (2021). Kinetics, pathways and toxicity of hexabromocyclododecane biodegradation: Isolation of the novel bacterium Citrobacter sp. Y3. Chemosphere. 274. 129929–129929. 12 indexed citations
15.
16.
Li, Yan, Yingyuan Lu, Jun Jia, et al.. (2021). A Novel System for Evaluating the Inhibition Effect of Drugs on Cytochrome P450 Enzymes in vitro Based on Human-Induced Hepatocytes (hiHeps). Frontiers in Pharmacology. 12. 748658–748658. 5 indexed citations
17.
Du, Zhiyong, Jinlong Wang, Yingyuan Lu, et al.. (2020). The cardiac protection of Baoyuan decoction via gut-heart axis metabolic pathway. Phytomedicine. 79. 153322–153322. 32 indexed citations
18.
Lu, Yingyuan, Zhiyong Du, Yan Li, et al.. (2018). Effects of Baoyuan decoction, a traditional Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats. Journal of Ethnopharmacology. 225. 327–335. 17 indexed citations
20.
Wang, Xin, Jian Li, Zhiyun Meng, et al.. (2015). Quantitative and qualitative analysis of the novel antitumor 1,3,4-oxadiazole derivative (GLB) and its metabolites using HPLC-UV and UPLC-QTOF-MS. Scientific Reports. 5(1). 11906–11906. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026